RICE HALL JAMES & ASSOCIATES, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$3,438,941
+11.6%
77,506
+20.1%
0.22%
+24.6%
Q2 2023$3,081,406
+8.4%
64,546
-10.7%
0.18%
+8.0%
Q1 2023$2,843,864
+37.3%
72,271
-1.3%
0.16%
+36.1%
Q4 2022$2,071,903
-9.6%
73,238
-3.9%
0.12%
-10.5%
Q3 2022$2,291,000
-11.2%
76,206
+0.2%
0.13%
+6.4%
Q2 2022$2,581,000
-29.0%
76,044
-6.3%
0.12%
-13.8%
Q1 2022$3,637,000
-39.4%
81,116
-37.6%
0.14%
-31.9%
Q4 2021$6,004,000
+48.5%
129,930
+7.9%
0.21%
+43.0%
Q3 2021$4,044,000
-35.2%
120,399
-43.3%
0.15%
-32.9%
Q2 2021$6,244,000
+5.2%
212,325
-7.8%
0.22%
+15.0%
Q1 2021$5,935,000
+13.8%
230,325
+0.7%
0.19%
+4.9%
Q4 2020$5,217,000
+10.2%
228,794
+3.3%
0.18%
-3.7%
Q3 2020$4,736,000
+37.3%
221,507
+49.1%
0.19%
+29.1%
Q2 2020$3,449,000
+134.5%
148,609
+115.6%
0.15%
+80.5%
Q1 2020$1,471,000
+10.8%
68,920
+21.3%
0.08%
+82.2%
Q4 2019$1,328,00056,8110.04%
Other shareholders
IRADIMED CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders